AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
QUALITY-CONTROL OF IMMUNOHISTOCHEMICAL EVALUATION OF TUMOR-ASSOCIATEDPLASMINOGEN ACTIVATORS AND RELATED COMPONENTS
Authors: RUITER DJ FERRIER CM VANMUIJEN GNP HENZENLOGMANS SC KENNEDY S KRAMER MD NIELSEN BS SCHMITT M
Citation: Dj. Ruiter et al., QUALITY-CONTROL OF IMMUNOHISTOCHEMICAL EVALUATION OF TUMOR-ASSOCIATEDPLASMINOGEN ACTIVATORS AND RELATED COMPONENTS, European journal of cancer, 34(9), 1998, pp. 1334-1340
AUTOANTIBODIES TO POLYMORPHONUCLEAR NEUTROPHIL ELASTASE DO NOT INHIBIT BUT ENHANCE ELASTASE ACTIVITY
Authors: MORCOS M ZIMMERMANN F RADSAK M WORNER I KRAMER MD ROLAND J HANSCH GM ANDRASSY K
Citation: M. Morcos et al., AUTOANTIBODIES TO POLYMORPHONUCLEAR NEUTROPHIL ELASTASE DO NOT INHIBIT BUT ENHANCE ELASTASE ACTIVITY, American journal of kidney diseases, 31(6), 1998, pp. 978-985
AUTOLOGOUS TRANSPLANTATION OF UROTHELIUM INTO DEMUCOSALIZED GASTROINTESTINAL SEGMENTS - EVIDENCE FOR EPITHELIALIZATION AND DIFFERENTIATION OF IN-VITRO EXPANDED AND TRANSPLANTED UROTHELIAL CELLS
Authors: SCHAEFER BM LORENZ C BACK W MOLL R SUN TT SCHOBER C WAAG KL KRAMER MD
Citation: Bm. Schaefer et al., AUTOLOGOUS TRANSPLANTATION OF UROTHELIUM INTO DEMUCOSALIZED GASTROINTESTINAL SEGMENTS - EVIDENCE FOR EPITHELIALIZATION AND DIFFERENTIATION OF IN-VITRO EXPANDED AND TRANSPLANTED UROTHELIAL CELLS, The Journal of urology, 159(1), 1998, pp. 284-290
EPITOPES OF COMPONENTS OF THE PLASMINOGEN ACTIVATION SYSTEM ARE RE-EXPOSED IN FORMALIN-FIXED PARAFFIN SECTIONS BY DIFFERENT RETRIEVAL TECHNIQUES
Authors: FERRIER CM VANGELOOF WL DEWITTE HH KRAMER MD RUITER DJ VANMUIJEN GNP
Citation: Cm. Ferrier et al., EPITOPES OF COMPONENTS OF THE PLASMINOGEN ACTIVATION SYSTEM ARE RE-EXPOSED IN FORMALIN-FIXED PARAFFIN SECTIONS BY DIFFERENT RETRIEVAL TECHNIQUES, The Journal of histochemistry and cytochemistry, 46(4), 1998, pp. 469-476
PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IS EXPRESSED IN KERATINOCYTES DURING REEPITHILIALIZATION OF EPIDERMAL DEFECTS
Authors: BECHTEL MJ WYSOCKI NS HEIDTMANN A STARK HJ FUSENIG N KRAMER MD SCHAEFER BM
Citation: Mj. Bechtel et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IS EXPRESSED IN KERATINOCYTES DURING REEPITHILIALIZATION OF EPIDERMAL DEFECTS, British journal of dermatology, 138(1), 1998, pp. 22-28
EXTERNAL QUALITY ASSESSMENT OF TRANS-EUROPEAN MULTICENTER ANTIGEN DETERMINATIONS (ENZYME-LINKED-IMMUNOSORBENT-ASSAY) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS TYPE-1 INHIBITOR (PAI-1) IN HUMAN BREAST-CANCER TISSUE-EXTRACTS
Authors: SWEEP CGJ GEURTSMOESPOT J GREBENSCHIKOV N DEWITTE JH HEUVEL JJTM SCHMITT M DUFFY MJ JANICKE F KRAMER MD FOEKENS JA BRUNNER N BRUGAL G PEDERSEN AN BENRAAD TJ
Citation: Cgj. Sweep et al., EXTERNAL QUALITY ASSESSMENT OF TRANS-EUROPEAN MULTICENTER ANTIGEN DETERMINATIONS (ENZYME-LINKED-IMMUNOSORBENT-ASSAY) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS TYPE-1 INHIBITOR (PAI-1) IN HUMAN BREAST-CANCER TISSUE-EXTRACTS, British Journal of Cancer, 78(11), 1998, pp. 1434-1441
SEMIQUANTITATION OF UROKINASE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR IN BREAST CARCINOMAS BY IMMUNOCYTOCHEMISTRY
Authors: KENNEDY S DUFFY MJ DUGGAN C BARNES C RAFFERTY R KRAMER MD
Citation: S. Kennedy et al., SEMIQUANTITATION OF UROKINASE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR IN BREAST CARCINOMAS BY IMMUNOCYTOCHEMISTRY, British Journal of Cancer, 77(10), 1998, pp. 1638-1641
RESPIRATORY SYMPTOMS IN THE IOWA FARM FAMILY HEALTH AND HAZARD SURVEY- ASSOCIATIONS WITH PESTICIDE EXPOSURES
Authors: SPRINCE NL LEWIS MQ WHITTEN PS REYNOLDS SJ KRAMER MD MERCHANT JA ZWERLING C
Citation: Nl. Sprince et al., RESPIRATORY SYMPTOMS IN THE IOWA FARM FAMILY HEALTH AND HAZARD SURVEY- ASSOCIATIONS WITH PESTICIDE EXPOSURES, American journal of epidemiology, 147(11), 1998, pp. 90-90
HEMODIALYSIS AND RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR OFHUMAN MO
Authors: KAZARNOVSKY T RITZ E REINARTZ J KRAMER MD
Citation: T. Kazarnovsky et al., HEMODIALYSIS AND RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR OFHUMAN MO, Journal of the American Society of Nephrology, 8, 1997, pp. 1108-1108
THORACOSCOPY IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: FLUM DR STEINBERG SD BERNIK TR BONFILSROBERTS E KRAMER MD ADAMS PX WALLACK MK
Citation: Dr. Flum et al., THORACOSCOPY IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Journal of thoracic and cardiovascular surgery, 114(3), 1997, pp. 361-366
PROGNOSTIC RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER
Authors: SOLOMAYER EF DIEL IJ WALLWIENER D BODE S MEYBERG G SILLEM M GOLLAN O KRAMER MD KRAINICK U BASTERT G
Citation: Ef. Solomayer et al., PROGNOSTIC RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER, British Journal of Cancer, 76(6), 1997, pp. 812-818
PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN BREAST-CANCER
Authors: DUGGAN C KENNEDY S KRAMER MD BARNES C ELVIN P MCDERMOTT E OHIGGINS N DUFFY MJ
Citation: C. Duggan et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN BREAST-CANCER, British Journal of Cancer, 76(5), 1997, pp. 622-627
HOMOZYGOUS TYPE-I PLASMINOGEN DEFICIENCY - TREATMENT AND PREVENTION OF BLINDNESS BY LONG-TERM REPLACEMENT THERAPY WITH LYS-PLASMINOGEN
Authors: SCHOTT D DEMPFLE CE LIERMAN A BECK P KRAMER MD LIESENHOFF H NIESSEN KH MOHRPENNERT A PHILAPITSCH A SCHUSTER V AZUMA H SCHWARZ HP
Citation: D. Schott et al., HOMOZYGOUS TYPE-I PLASMINOGEN DEFICIENCY - TREATMENT AND PREVENTION OF BLINDNESS BY LONG-TERM REPLACEMENT THERAPY WITH LYS-PLASMINOGEN, Blood, 90(10), 1997, pp. 2666-2666
AN ASSOCIATION OF HERBICIDE EXPOSURE TO WHEEZING AMONG IOWA FARM CHILDREN
Authors: KRAMER MD SPRINCE NL WHITTEN PS ZWERLING C
Citation: Md. Kramer et al., AN ASSOCIATION OF HERBICIDE EXPOSURE TO WHEEZING AMONG IOWA FARM CHILDREN, American journal of epidemiology, 145(11), 1997, pp. 76-76
UP-REGULATION OF THE CELL-SURFACE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA-R CD87) IN PERIPHERAL-BLOOD MONOCYTES OF PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
Authors: KAZARNOVSKY T RITZ E REINARTZ J KRAMER MD
Citation: T. Kazarnovsky et al., UP-REGULATION OF THE CELL-SURFACE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA-R CD87) IN PERIPHERAL-BLOOD MONOCYTES OF PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1187-1187
ADENOSYLATION OF THE DOPAMINE D-4, RECEPTOR CAUSES SPONTANEOUS ACTIVITY
Authors: KRAMER MD KOTB M DETH RC
Citation: Md. Kramer et al., ADENOSYLATION OF THE DOPAMINE D-4, RECEPTOR CAUSES SPONTANEOUS ACTIVITY, The FASEB journal, 10(3), 1996, pp. 2425-2425
PLASMINOGEN ACTIVATION IN BULLOUS PEMPHIGOID IMMUNOHISTOLOGY REVEALS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN LESIONAL EPIDERMIS
Authors: SCHAEFER BM JAEGER C DREPPER E KRAMER MD
Citation: Bm. Schaefer et al., PLASMINOGEN ACTIVATION IN BULLOUS PEMPHIGOID IMMUNOHISTOLOGY REVEALS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN LESIONAL EPIDERMIS, Autoimmunity, 23(3), 1996, pp. 155
INTERLEUKIN-1-BETA UP-REGULATES TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A KERATINOCYTE CELL-LINE (HACAT)
Authors: ROX JM REINARTZ J KRAMER MD
Citation: Jm. Rox et al., INTERLEUKIN-1-BETA UP-REGULATES TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A KERATINOCYTE CELL-LINE (HACAT), Archives of dermatological research, 288(9), 1996, pp. 554-558
ALPHA(2)-ANTIPLASMIN AND PLASMINOGEN-ACTIVATOR INHIBITORS IN HEALING HUMAN SKIN WOUNDS
Authors: SCHAEFER BM MAIER K EICKHOFF U BECHTEL M KRAMER MD
Citation: Bm. Schaefer et al., ALPHA(2)-ANTIPLASMIN AND PLASMINOGEN-ACTIVATOR INHIBITORS IN HEALING HUMAN SKIN WOUNDS, Archives of dermatological research, 288(3), 1996, pp. 122-128
CELL DENSITY-DEPENDENT DOWN-REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN TRANSFORMED HUMAN EPIDERMAL-KERATINOCYTES
Authors: INNDORF S BECHTEL MJ REINARTZ J KRAMER MD
Citation: S. Inndorf et al., CELL DENSITY-DEPENDENT DOWN-REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN TRANSFORMED HUMAN EPIDERMAL-KERATINOCYTES, Archives of dermatological research, 288(12), 1996, pp. 783-785
THE RECOMBINANT OUTER SURFACE PROTEIN-A (LIPOSPA) OF BORRELIA-BURGDORFERI - A LYME-DISEASE VACCINE
Authors: WALLICH R KRAMER MD SIMON MM
Citation: R. Wallich et al., THE RECOMBINANT OUTER SURFACE PROTEIN-A (LIPOSPA) OF BORRELIA-BURGDORFERI - A LYME-DISEASE VACCINE, Infection, 24(5), 1996, pp. 396-397
TICK FACTORS AND IN-VITRO CULTIVATION INFLUENCE THE PROTEIN PROFILE, ANTIGENICITY AND PATHOGENICITY OF A CLONED BORRELIA-GARINII ISOLATE FROM IXODES-RICINUS HEMOLYMPH
Authors: HU CM SIMON M KRAMER MD GERN L
Citation: Cm. Hu et al., TICK FACTORS AND IN-VITRO CULTIVATION INFLUENCE THE PROTEIN PROFILE, ANTIGENICITY AND PATHOGENICITY OF A CLONED BORRELIA-GARINII ISOLATE FROM IXODES-RICINUS HEMOLYMPH, Infection, 24(3), 1996, pp. 251-257
THE OUTER SURFACE PROTEIN-A (OSPA) OF BORRELIA-BURGDORFERI - A VACCINE CANDIDATE AND BIOACTIVE MEDIATOR
Authors: KRAMER MD WALLICH R SIMON MM
Citation: Md. Kramer et al., THE OUTER SURFACE PROTEIN-A (OSPA) OF BORRELIA-BURGDORFERI - A VACCINE CANDIDATE AND BIOACTIVE MEDIATOR, Infection, 24(2), 1996, pp. 190-194
RAPID NORMALIZATION OF EPIDERMAL INTEGRIN EXPRESSION AFTER ALLOGRAFTING OF HUMAN KERATINOCYTES
Authors: LANG E SCHAEFER BM EICKHOFF U HOHL HP KRAMER MD MAIERREIF K
Citation: E. Lang et al., RAPID NORMALIZATION OF EPIDERMAL INTEGRIN EXPRESSION AFTER ALLOGRAFTING OF HUMAN KERATINOCYTES, Journal of investigative dermatology, 107(3), 1996, pp. 423-427
BORRELIA BURGDORFI INDUCES SECRETION OF PRO-UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY HUMAN MONOCYTES
Authors: FUCHS H SIMON MM WALLICH R BECHTEL M KRAMER MD
Citation: H. Fuchs et al., BORRELIA BURGDORFI INDUCES SECRETION OF PRO-UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY HUMAN MONOCYTES, Infection and immunity, 64(10), 1996, pp. 4307-4312
Risultati: 1-25 | 26-50 | 51-72